Radiation Oncology Journal

A case of multiple hepatocellular carcinoma experiencing complete responses to sorafenib and atezolizumab–bevacizumab and developing severe, refractory venous congestive cutaneous ulcers on either regimen

Yorihito Hayashi, Rena Kaneko, Hiroki Ogino, Toshimasa Uekusa, Mayako Kitajima, Takashi Ikehara, Hidenari Nagai, Takahisa Matsuda

Clinical Journal of Gastroenterology.2023; 16(2): 229. CrossRef

Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience

David Boyce-Fappiano, Olsi Gjyshi, Todd A. Pezzi, Pamela K. Allen, Moaaz Solimman, Nicolette Taku, Michael B. Bernstein, Maria E. Cabanillas, Behrang Amini, Claudio E. Tatsui, Laurence D. Rhines, Xin A. Wang, Tina M. Briere, Debra Nana Yeboa, Andrew J. Bi

Journal of Neurosurgery: Spine.2020; 32(6): 941. CrossRef

Hematuria induced by combination regorafenib and hyperthermia – a radiation recall effect

Yu-Mei Zheng, Jyh-Ming Chow, Chia-Lun Chang, Liang-Hsiao Chao, Jacqueline Whang-Peng, Gi-Ming Lai

International Journal of Hyperthermia.2019; 36(1): 1185. CrossRef

Radiation Recall Dermatitis in Patients Treated with Sorafenib

Keyur Mehta, Andreas Kaubisch, Justin Tang, Aneesh Pirlamarla, Shalom Kalnicki

Case Reports in Oncological Medicine.2018; 2018: 1. CrossRef

Reacciones cutáneas a fármacos en el paciente con leucemia/linfoma

Mar Llamas-Velasco, Pedro Rodríguez-Jiménez, Pablo Chicharro, Javier Sánchez-Pérez

Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment

Francesco Borgia, Carlo Saitta, Mario Vaccaro, Maria Stella Franzè, Maria Lentini, Serafinella Patrizia Cannavò

International Journal of Immunopathology and Pharmacology.2017; 30(3): 327. CrossRef

Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma

Gwi Eon Kim, Hee-Sung Song, Ki Jung Ahn, Young Suk Kim

Radiation Oncology Journal.2017; 35(3): 289. CrossRef

Radiation recall dermatitis induced by sorafenib

Sonja Stieb, Oliver Riesterer, Cornelia Brüssow, Bernhard Pestalozzi, Matthias Guckenberger, Stefan Weiler

Strahlentherapie und Onkologie.2016; 192(5): 342. CrossRef

Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients

Olivier Huillard, Emilie Boissier, Benoit Blanchet, Audrey Thomas-Schoemann, Anatole Cessot, Pascaline Boudou-Rouquette, Jean-Philippe Durand, Romain Coriat, Julie Giroux, Jerome Alexandre, Michel Vidal, Francois Goldwasser

Expert Opinion on Drug Safety.2014; 13(5): 663. CrossRef